Drugs / hypertonic saline solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00447018 | Oct 2002 → Jun 2005 | intracranial hypertension | University Hospital, Grenoble | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hypertonic saline solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00447018 ↗ |
| Known as | HSS | “The growing interest in the use of hypertonic saline solutions (HSS) in this clinical setting has, however, challenged the use of mannitol.” NCT00447018 ↗ |
| Route | Intravenous | “Equimolar, rapid intravenous infusions of either 200 mL of 20% mannitol or 100 mL of 7.5% saline and 6% dextran-70 solution (HSD) over 5 mins.” PMID 15644669 ↗ Jan 2005 |